Mereo BioPharma Group Stock (NASDAQ: MREO)

Dernières nouvelles pour Mereo BioPharma Group (NASDAQ:MREO) Stock

MEREO BIOPHARMA GROUP PL-ADR

Mereo BioPharma Group

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

News

Press Releases

Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference

Earnings

Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference

Mereo BioPharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Analyst Ratings

Mereo BioPharma Provides Update on Lead Clinical Programs

Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Healthcare Conference

Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights

Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights

Ultragenyx and Mereo BioPharma Announce UX143 Phase 3 Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO

MREO

RARE

Aldeyra Therapeutics, Inc. - Common Stock

Aldeyra Therapeutics

Allogene Therapeutics, Inc. - Common Stock

Allogene Therapeutics

Annexon

Benitec Biopharma

Perspective Therapeutics, Inc. Common Stock

Perspective Therapeutics

Crescent Biopharma

Cardiff Oncology

DBV Technologies S.A. - American Depositary Shares

DBV Technologies

Design Therapeutics

Editas Medicine

Heron Therapeutics

Immutep Limited - American Depositary Shares

Immutep

Kodiak Sciences

Monopar Therapeutics

Mereo BioPharma Group plc - American Depositary Shares

Nanobiotix

Ocugen

Olema Pharmaceuticals, Inc. - Common Stock

Olema Pharmaceuticals

Rocket Pharmaceuticals, Inc. - Common Stock

Rocket Pharmaceuticals

Sagimet Biosciences Inc. - Series A Common Stock

Sagimet Biosciences

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics

Entrada Therapeutics, Inc. - Common Stock

Entrada Therapeutics

Tevogen Bio Holdings

Vanda Pharmaceuticals Inc. - Common Stock

Comments

Mereo BioPharma Group

Actualités

Dernières nouvelles pour Mereo BioPharma Group (NASDAQ:MREO) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL